Ignite Creation Date:
2025-12-25 @ 3:23 AM
Ignite Modification Date:
2026-01-12 @ 6:26 AM
Study NCT ID:
NCT00999505
Status:
UNKNOWN
Last Update Posted:
2011-02-16
First Post:
2009-10-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2025-12-24', 'submissionTracking': {'submissionInfos': [{'resetDate': '2016-10-10', 'releaseDate': '2016-08-17'}, {'resetDate': '2017-04-05', 'releaseDate': '2017-02-22'}], 'estimatedResultsFirstSubmitDate': '2016-08-17'}}, 'conditionBrowseModule': {'meshes': [{'id': 'D012559', 'term': 'Schizophrenia'}], 'ancestors': [{'id': 'D019967', 'term': 'Schizophrenia Spectrum and Other Psychotic Disorders'}, {'id': 'D001523', 'term': 'Mental Disorders'}]}, 'interventionBrowseModule': {'meshes': [{'id': 'D000547', 'term': 'Amantadine'}], 'ancestors': [{'id': 'D000218', 'term': 'Adamantane'}, {'id': 'D001952', 'term': 'Bridged-Ring Compounds'}, {'id': 'D006844', 'term': 'Hydrocarbons, Cyclic'}, {'id': 'D006838', 'term': 'Hydrocarbons'}, {'id': 'D009930', 'term': 'Organic Chemicals'}]}}, 'protocolSection': {'designModule': {'phases': ['PHASE3'], 'studyType': 'INTERVENTIONAL', 'designInfo': {'allocation': 'RANDOMIZED', 'maskingInfo': {'masking': 'QUADRUPLE', 'whoMasked': ['PARTICIPANT', 'CARE_PROVIDER', 'INVESTIGATOR', 'OUTCOMES_ASSESSOR']}, 'primaryPurpose': 'TREATMENT', 'interventionModel': 'PARALLEL'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 40}}, 'statusModule': {'overallStatus': 'UNKNOWN', 'lastKnownStatus': 'RECRUITING', 'startDateStruct': {'date': '2010-05'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2011-02', 'completionDateStruct': {'date': '2011-09', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2011-02-15', 'studyFirstSubmitDate': '2009-10-20', 'studyFirstSubmitQcDate': '2009-10-20', 'lastUpdatePostDateStruct': {'date': '2011-02-16', 'type': 'ESTIMATED'}, 'studyFirstPostDateStruct': {'date': '2009-10-21', 'type': 'ESTIMATED'}, 'primaryCompletionDateStruct': {'date': '2011-09', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Scores in Brief Psychiatric Rating Scale', 'timeFrame': 'Baseline, 4 weeks, 8 weeks, 12 weeks'}]}, 'oversightModule': {'oversightHasDmc': False}, 'conditionsModule': {'keywords': ['Schizophrenia', 'Amantadine', 'Residual symptoms'], 'conditions': ['Schizophrenia']}, 'descriptionModule': {'briefSummary': 'Amantadine as add-on therapy to antipsychotics may improve schizophrenia positive, negative and cognitive symptoms.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT'], 'maximumAge': '60 Years', 'minimumAge': '18 Years', 'healthyVolunteers': False, 'eligibilityCriteria': 'Inclusion Criteria:\n\n* Under antipsychotics with residual symptoms\n\nExclusion Criteria:\n\n* Pregnancy\n* Lactation'}, 'identificationModule': {'nctId': 'NCT00999505', 'briefTitle': 'Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia', 'organization': {'class': 'OTHER', 'fullName': 'Hospital de Clinicas de Porto Alegre'}, 'officialTitle': 'A Double-blind, Randomized, Placebo-controlled Trial With Amantadine as Adjunctive Therapy to Antipsychotics in Schizophrenia', 'orgStudyIdInfo': {'id': '09-303'}, 'secondaryIdInfos': [{'id': '09-303'}]}, 'armsInterventionsModule': {'armGroups': [{'type': 'ACTIVE_COMPARATOR', 'label': 'Amantadine', 'description': 'Amantadine 200mg twice a day', 'interventionNames': ['Drug: Amantadine']}, {'type': 'PLACEBO_COMPARATOR', 'label': 'Placebo', 'description': 'Placebo capsules twice a day', 'interventionNames': ['Drug: Placebo']}], 'interventions': [{'name': 'Amantadine', 'type': 'DRUG', 'otherNames': ['Mantidan TM'], 'description': 'Amantadine 200mg twice a day over 12 weeks', 'armGroupLabels': ['Amantadine']}, {'name': 'Placebo', 'type': 'DRUG', 'description': 'Placebo capsules twice a day over 12 weeks', 'armGroupLabels': ['Placebo']}]}, 'contactsLocationsModule': {'locations': [{'zip': '90035-903', 'city': 'Porto Alegre', 'state': 'Rio Grande do Sul', 'status': 'RECRUITING', 'country': 'Brazil', 'contacts': [{'name': 'David Lucena, MD', 'role': 'SUB_INVESTIGATOR'}], 'facility': 'Hospital de Clinicas de Porto Alegre', 'geoPoint': {'lat': -30.03283, 'lon': -51.23019}}], 'centralContacts': [{'name': 'Clarissa S Gama, MD, PhD', 'role': 'CONTACT', 'email': 'csgama@yahoo.com', 'phone': '55-51-33598745'}], 'overallOfficials': [{'name': 'Clarissa S Gama, MD, PhD', 'role': 'PRINCIPAL_INVESTIGATOR', 'affiliation': 'Hospital de Clinicas de Porto Alegre'}]}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'Hospital de Clinicas de Porto Alegre', 'class': 'OTHER'}, 'responsibleParty': {'oldNameTitle': 'Clarissa Severino Gama, MD, PhD', 'oldOrganization': 'Hospital de Clinicas de Porto Alegre'}}}, 'annotationSection': {'annotationModule': {'unpostedAnnotation': {'unpostedEvents': [{'date': '2016-08-17', 'type': 'RELEASE'}, {'date': '2016-10-10', 'type': 'RESET'}, {'date': '2017-02-22', 'type': 'RELEASE'}, {'date': '2017-04-05', 'type': 'RESET'}], 'unpostedResponsibleParty': 'Clarissa Severino Gama, Professor of Psychiatry, Hospital de Clinicas de Porto Alegre'}}}}